drugset / Trial / NCT02011542
Probiotic (VSL #3) for Gulf War Illness
RandomizedParallel-groupTriple-blindTreatment
Summary
The overall objective is to determine whether VSL #3 will improve 1) intestinal symptoms of Irritable Bowel Syndrome (IBS) and 2) non-intestinal symptoms (fatigue, joint pain, insomnia, general stiffness and headache) associated with IBS. All of these symptoms are part of the Gulf War (GW) illness.
Timeline
- Start
- 2013-09
- Primary completion
- 2016-07
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | VSL#3 | Other / unclassified | — | — |